The Autoinjectors Market is expected to witness a growth rate of 14-16% by 2028. The key factors driving the market are the ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2025 Earnings Conference ... where we're studying orforglipron compared to insulin and head to head versus other ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Finding new ways to control blood sugar was the perfect test case. “When I arrived, there was a moment to go beyond insulin,” says Ricks. In the early 2000s, Lilly partnered with biotech ...

A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a ...

The deal, announced in March and set to close in the second quarter, marks the Swiss pharma's latest bid to compete with weight loss heavyweights Novo Nordisk and Eli Lilly, after building out its ...